Similar survival but increased toxicity with a sequential versus concurrent FluBu4 regimen

Bone Marrow Transplant. 2018 Sep;53(9):1221-1224. doi: 10.1038/s41409-018-0195-4. Epub 2018 Apr 27.

Karen Sweiss^{1

2}, Annie Oh³, Gregory Calip⁴, Damiano Rondelli^{5

3}, Pritesh Patel^{5

3}

¹ Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA. ksweis2@uic.edu.
² Cancer Center, University of Illinois, Chicago, IL, USA. ksweis2@uic.edu.
³ Division of Hematology/ Oncology, University of Illinois at Chicago, Chicago, IL, USA.
⁴ Center for Pharmacoepidemiology and Pharmacoeconomic Research, Chicago, IL, USA.
⁵ Cancer Center, University of Illinois, Chicago, IL, USA.

No abstract available

Publication types